The present invention relates to oxazolopyrimidine compounds of the formula I, in which A, R1, R2, R3 and X are defined as indicated in the claims. The compounds of the formula I modulate the activity of the Edg-1 receptor and in particular are agonists of this receptor, and are useful for the treatment of diseases such as atherosclerosis, heart failure or peripheral arterial occlusive disease, for example. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.본 발명은 화학식 I의 옥사졸로피리미딘 화합물에 관한 것이다. 화학식 I상기 화학식 I에서, A, R1, R2, R3 및 X는 특허청구범위에 기술된 바와 같이 정의된다.상기 화학식 I의 화합물은, 예를 들면, 상처 치유에 적합하다.
